A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Clinical trial NCT03821233 · COMPLETED

Trial details

NCT number: NCT03821233
Sponsor: Zymeworks BC Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-expressing Cancers

Start date: 2019-04-15
Primary completion: 2024-09-27
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.